研究代号 raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
This page was last updated on 2026-04-27 and is reviewed periodically as new material appears.
Development has progressed from single- and multiple-ascending-dose studies in healthy volunteers into larger randomized trials in adults with obesity, type 2 diabetes, and fatty liver disease. Early reports describe dose-dependent reductions in body weight and improvements in glycemic markers over treatment periods of several months. Whether the glucagon arm adds tolerability cost without added benefit is still debated. Long-term cardiovascular outcomes, effects after treatment stops, and performance in older or comorbid populations are open questions rather than settled findings. Approval status may change, so the current investigational label should be confirmed against regulatory sources.
Retatrutide is an investigational synthetic peptide developed under the code LY3437943, with a backbone derived from glucose-dependent insulinotropic polypeptide. Several non-proteinogenic residues, including alpha-aminoisobutyric acid, appear in that backbone, and a fatty diacid side chain attached through a linker extends circulation time. The molecule carries roughly thirty-nine amino acid units and a total mass near 4.7 kilodaltons. Administration is by subcutaneous injection once weekly. Published work uses both the name retatrutide and the code LY3437943.
Human evidence remains limited to controlled studies. A phase 2 trial in adults with obesity reported large, dose-dependent reductions in body weight over 48 weeks, with gastrointestinal events as the most frequently recorded adverse effect. Phase 3 programs designated TRIUMPH, for obesity, and TRANSCEND, for type 2 diabetes, are intended to confirm efficacy and to characterize safety in larger populations. Related studies are examining conditions such as knee osteoarthritis in people with obesity and metabolic liver disease. Open questions include long-term tolerability, effects on lean mass, and what happens after treatment is stopped.
Retatrutide is an investigational synthetic peptide that acts on three receptor targets at once: glucose-dependent insulinotropic polypeptide, glucagon-like peptide-1, and glucagon. It is developed by Eli Lilly and appears in the literature and in trial registries under the code LY3437943. The molecule belongs to a class of engineered peptides designed to resist rapid breakdown and permit infrequent subcutaneous administration. No regulatory agency has approved it for clinical use, and all available human data come from controlled trials rather than from routine practice.
The intended pharmacology combines three signals in one molecule. GLP-1 receptor activation reduces appetite and slows gastric emptying, effects already exploited by approved incretin-based therapies. GIP receptor engagement is associated with improved insulin sensitivity and with direct effects on adipose tissue, although how much it contributes to overall outcomes is still debated. Glucagon receptor agonism raises energy expenditure and supports hepatic lipid handling, a mechanism that also tends to increase glucose output. The triple profile is hypothesized to produce a larger metabolic effect than single or dual agonism, but the relative weight of each receptor in humans is not settled.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic peptide of about 39 residues | Backbone derived from a GIP sequence |
| Molecular mass | Approximately 4.7 kDa | Peptide chain plus fatty diacid moiety |
| Receptor targets | GLP-1, GIP, glucagon | Unimolecular triple agonist |
| Typical storage temperature | 2 to 8 degrees Celsius | Protect from light; avoid repeated freeze-thaw |
| Common analytical method | LC-MS/MS | Used for plasma quantification and purity checks |
冻干粉通常在低温环境下保存，复溶之后需要按指定条件在较短时间内使用。反复冻融和剧烈振荡可能促进聚集，低吸附容器则能减少多肽在管壁上的损失。批号、日期与处理条件的完整记录，是后续复核与问题追溯的基础。
供应环节涉及来源核实与文件审核两类工作。分析证书、批次记录以及第三方检测报告构成常见的可追溯材料。来源不清的样品很难确认身份与纯度，因此核实步骤在实际操作中具有明确意义。缺少方法细节的报告通常无法复核。
多肽类化合物的表征通常依赖色谱与质谱联用技术。反相高效液相色谱用于评估纯度与有关物质，质谱用于确认分子量，肽图分析通过酶解碎片比对验证一级结构。这些手段组合使用，可以把目标产物与降解产物或类似物区分开来。单一方法往往不足以完成完整确认。
Clinical development has advanced through phase 2 trials in adults with obesity and type 2 diabetes. Reported phase 2 results described substantial average weight reduction over roughly forty-eight weeks of weekly dosing. A phase 3 program is ongoing to confirm efficacy and assess long-term safety. Because the compound has not received regulatory approval, it is not available as a prescription product. Public discussion of retatrutide often conflates trial findings with marketed status, an important distinction when interpreting coverage of the topic.
Retatrutide is a synthetic peptide developed as a single molecule that activates three distinct hormone receptors: GLP-1, GIP, and glucagon. The compound carries the internal designation LY3437943 and was engineered by modifying the backbone of glucose-dependent insulinotropic polypeptide. Its sequence incorporates non-natural amino acids and a fatty acid side chain that extends circulation time. The triple-agonist design aims to combine appetite suppression, improved insulin response, and increased energy expenditure in one agent. Published reports describe it as an investigational product rather than an approved medicine.
与仅靶向单一受体的同类药物相比，瑞他鲁肽增加胰高血糖素受体成分，理论上可提高能量消耗并改变脂肪分布。临床中观察到的体重变化是否主要来自该额外机制，目前尚无定论。胃肠道反应是该类药物常见不良事件，试验中通过剂量递增和监测进行管理。停药后体重反弹、个体差异和长期耐受性仍需更多数据。
瑞他鲁肽是一种在研合成肽，同时作用于胰高血糖素样肽-1、葡萄糖依赖性促胰岛素多肽和胰高血糖素受体。该分子属于多受体激动剂类别，尚未获得任何监管机构的上市批准。当前临床开发主要针对肥胖和2型糖尿病，研究代号为LY3437943。已确立的信息包括受体靶点和部分中期试验结果；最终疗效、长期安全性和适用人群仍属开放问题。
The yellow pulp, which contains the seeds, is naturally sweet and is processed into a valuable carbohydrate food. The seeds are processed into a seasoning, known as sikomu and dodowa/ dawadawa among the Yoruba and Hausa people respectively, and sunbala in the Inner Niger Delta. The pulp is also used to make beverages. The seeds of the locust bean are the most valuable part of the plant. They are high in lipids (29%), protein (35%), carbohydrates (16%), and are a good source of fat and calcium for rural dwellers. The seed is first cooked to remove the seed coat and then fermented to produce the desired result. Seeds can then be pounded into powder, then formed into cakes. In a study conducted on the fermentation of dawadawa, it was found that Gmelina arborea and banana leaves accelerated fermentation of seeds, while increasing fat, protein and moisture content, but also decreasing carbohydrate content.
=== The 12 nidānas as an early list === Against the view that the 12 link chain is later, Alex Wayman writes "I am convinced that the full twelve members have been in Buddhism since earliest times, just as it is certain that a natural division into the first seven and last five was also known." Bhikkhu Bodhi writes that the suggestions of some scholars the twelvefold formula is a later expansion of a shorter list "remain purely conjectural, misleading, and objectionable on doctrinal and textual grounds." Choong, in his comparative study of SN and SA also writes that the different accounts of dependent origination existed at an early stage and that they are simply different ways of presenting the same teaching which would have been used for different times and with audiences. Choong writes that the various versions of dependent arising "are unlikely to represent a progressive development, with some being earlier and others later" and that "the comparative data revealed here do not provide evidence to support the speculative suggestion that there was just one original (or relatively early) account of the series, from which the other attested accounts developed later."
===== MHCI presentation ===== In the simplified view of this pathway HSPs are usually not mentioned: antigenic peptides are generated in proteasome, transported into ER through protein transporter TAP and loaded onto MHCI, which then goes through secretory pathway on plasma membrane. But HSPs play an important part in transfer of unfolded proteins to proteasome and generated peptides to MHCI. Hsp90 can associate with proteasome and take over generated peptides. Afterwards, it can associate with hsp70, which can take the peptide further to the TAP. After passing through TAP, ER chaperons are getting important - calreticulin binds peptides and together with gp96 form peptide loading complex for MHCI. This handing over with peptides is important, because HSPs can shield hydrophobic residues in peptides which would be otherwise problematic in aquatic cytosol. Also simple diffusion of peptides would be too ineffective.
It can occur as a result of a pre-existing infection or one acquired during pregnancy. Iatrogenic transmission, due to medical procedures such as injection or transplantation of infected material. Vector-borne transmission, transmitted by a vector, which is an organism that does not cause disease itself but that transmits infection by conveying pathogens from one host to another. The relationship between virulence versus transmissibility is complex; with studies showing no clear relationships between the two. There is still a small number of evidence that partially suggests a link between virulence and transmissibility.
=== 5 June === Ukrainian forces were reported to be advancing towards Bakhmut, with the Wagner Group's Yevgeny Prigozhin confirming that Ukrainian soldiers had retaken part of the settlement of Berkhivka, north of the city. Hanna Malyar, Ukrainian Deputy Defence Minister said that 'offensive actions' were underway in "some areas" in eastern Ukraine, adding that Ukrainian troops gained from 200 to 1,600 meters (660 to 5,250 ft) in Orikhovo-Vasulivka and Paraskoviivka, while in Ivanivske and Klishchiivka they advanced between 100 and 700 meters (330 and 2,300 ft). The Russian defense ministry said it was holding back attacks by Ukrainian forces near the settlements of Novodonetske and Oktyabrske. The Ukrainian government accused Russia of violating the terms of the Black Sea Grain Initiative by registering two vessels that declared their participation in the deal the same day, adding it went against accepted vessel inspection rules that required priority inspection and registration of longer-standing ships. The Wagner Group said it had detained a regular Russian military officer who opened fire on one of their vehicles near Bakhmut. The officer was said to have disliked the group and attacked the vehicle while intoxicated. The officer was later identified as Lt. Col. Roman Venevitin, who was later released and subsequently accused the group of stoking "anarchy" on Russia's frontlines by stealing arms, forcing mobilized soldiers to sign contracts with the group and attempting to extort weapons from the defence ministry.
Sources: en.wikipedia.org
=== Books === Nanotechnology in Drug Delivery (2008) ISBN 978-0387776675 Silk: Properties, Production and Uses (2012) ISBN 978-1621006923 Sustainable Uses of Byproducts from Silk Processing (2021) ISBN 978-3527347865
=== Chemical properties === The attractive forces between polymer chains play a large part in determining the polymer's properties. Because polymer chains are so long, they have many such interchain interactions per molecule, amplifying the effect of these interactions on the polymer properties in comparison to attractions between conventional molecules. Different side groups on the polymer can lend the polymer to ionic bonding or hydrogen bonding between its own chains. These stronger forces typically result in higher tensile strength and higher crystalline melting points. The intermolecular forces in polymers can be affected by dipoles in the monomer units. Polymers containing amide or carbonyl groups can form hydrogen bonds between adjacent chains; the partially positively charged hydrogen atoms in N-H groups of one chain are strongly attracted to the partially negatively charged oxygen atoms in C=O groups on another. These strong hydrogen bonds, for example, result in the high tensile strength and melting point of polymers containing urethane or urea linkages. Polyesters have dipole-dipole bonding between the oxygen atoms in C=O groups and the hydrogen atoms in H-C groups. Dipole bonding is not as strong as hydrogen bonding, so a polyester's melting point and strength are lower than Kevlar's (Twaron), but polyesters have greater flexibility. Polymers with non-polar units such as polyethylene interact only through weak Van der Waals forces. As a result, they typically have lower melting temperatures than other polymers.
=== Women === In 2021, the World Economic Forum ranked Belize 90th out of 156 countries in its Global Gender Gap Report. Of all the countries in Latin America and the Caribbean, Belize ranked fourth from last. It ranked higher in the categories of "economic participation and opportunity" and "health and survival", but very low in "political empowerment". In 2019, the UN gave Belize a Gender Inequality Index score of 0.415, ranking it 97th out of 162 countries. As of 2019, 49.9% of women in Belize participate in the workforce, compared to 80.6% of men. 11.1% of the seats in Belize's National Assembly are filled by women.
== Clinical services == The institution is a specialist hospital covering the major fields of dentistry and oral and maxillofacial medicine. Its clinical departments include cariology and endodontics, periodontics, oral medicine, prosthodontics, implant dentistry, orthodontics, pediatric dentistry, preventive dentistry and general dentistry, as well as several oral and maxillofacial surgical services. Its surgical services include head and neck oncology, trauma and reconstructive surgery, orthognathic and temporomandibular-joint surgery, and cleft lip and palate surgery. Supporting departments include oral pathology, radiology, anesthesia, pharmacy, clinical laboratory services and dental technology. The hospital identifies eight areas as national key clinical specialties: cariology and endodontics, periodontics, oral and maxillofacial surgery, prosthodontics, orthodontics, oral implantology, pediatric dentistry and oral mucosal disease. It also serves as a national standardized residency-training base and is involved in the national qualification examination and examiner training system for stomatology. The hospital records more than one million outpatient and emergency visits annually. Its emergency dentistry department provides 24-hour treatment for conditions including acute dental pain, oral infection, bleeding and dental or maxillofacial trauma.
Sources: en.wikipedia.org
As of the mid-2020s retatrutide remains investigational and is not an approved medicine in the United States or the European Union. It has been supplied mainly to participants in clinical trials. Labels and availability can change, so regulatory listings should be checked directly.
Dual agonists act at the GLP-1 and GIP receptors, whereas retatrutide adds glucagon receptor activity on the same peptide. This third activity is the main structural and pharmacological distinction discussed in the literature. Direct head-to-head comparisons remain limited.
Reports usually give the study code LY3437943 alongside the name, the dose in milligrams, and the week at which an endpoint was measured. Percent body-weight change is the most frequent headline measure. Units and populations vary, so comparisons across reports require care.
It is an investigational peptide that activates three hormone receptors: GIP, GLP-1 and glucagon. It is being studied mainly for obesity and type 2 diabetes, and it is not approved for any clinical use. Published information comes from controlled trials rather than from general practice.